Register entryShortage reported

Nephron Pharmaceuticals Corporation

Registered sites
0
Drug products
12
Live patents
0
Countries
0
Base
Unknown
Sites

Facilities

0

No registered facilities

This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.

Alert

Products in shortage

2
DrugPresentationAvailability
Albuterol Sulfate SolutionAlbuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 0487-9901-30)Available
Sterile Water InjectionSterile Water, Injection, 1 mL/1 mL (NDC 0487-6105-01)Limited Availability
Catalogue

Marketed products

12

Showing 12 of 12.

BrandGeneric nameFormCategory
Albuterol SulfateAlbuterol SulfateSOLUTIONANDA
Albuterol SulfateAlbuterol SulfateSOLUTIONANDA
Albuterol SulfateAlbuterol SulfateSOLUTIONANDA
Albuterol SulfateAlbuterol SulfateSOLUTIONANDA
BudesonideBUDESONIDEINHALANTANDA
BudesonideBUDESONIDEINHALANTANDA
Ipratropium BromideIpratropium BromideSOLUTIONANDA
Ipratropium Bromide and Albuterol SulfateIpratropium Bromide and Albuterol SulfateSOLUTIONANDA
Ketorolac TromethamineKetorolac TromethamineINJECTIONANDA
S2racepinephrine hydrochlorideSOLUTIONOTC MONOGRAPH DRUG
Sodium ChlorideSodium ChlorideINJECTIONANDA
Sterile WaterSterile WaterINJECTIONANDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.